Systematic Review

Published on 31 Oct 2024

Associations between tertiary lymphoid structure density and immune checkpoint inhibitor efficacy in solid tumors: systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Bin Jiang
Zhuo Wu
Yang Zhang
Xueying Yang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1414884

824 views

Original Research

Published on 31 Oct 2024

Insights into the historical trajectory and research trends of immune checkpoint blockade in colorectal cancer: visualization and bibliometric analysis

in Cancer Immunity and Immunotherapy

Yonglong Chang
Xuhui Zhou
Kechao Nie
Jinhui Liu
Sifang Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1478773

651 views

Original Research

Published on 31 Oct 2024

Transcriptomics profiling of the non-small cell lung cancer microenvironment across disease stages reveals dual immune cell-type behaviors

in Cancer Immunity and Immunotherapy

Marcelo Hurtado
Leila Khajavi
Abdelmounim Essabbar
Michael Kammer
Ting Xie
Alexis Coullomb
Anne Pradines
Anne Casanova
Anna Kruczynski
Sandrine Gouin

Frontiers in Immunology

doi 10.3389/fimmu.2024.1394965

522 views

Mini Review

Published on 31 Oct 2024

Role and therapeutic potential of E3s in the tumor microenvironment of hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Hailin Wang
Qiang Li
Qinqin Tang
Gang Shi
Guo Wu
Xingbo Mao
Changkang Wu
Lixin Zhang
Jie Liu
Jingdong Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1483721

605 views

Review

Published on 31 Oct 2024

Critical role of non-coding RNA-mediated ferroptosis in urologic malignancies

in Cancer Immunity and Immunotherapy

Wei Li
Liying Zheng
Peiyue Luo
Tao Chen
Jun Zou
Qi Chen
Le Cheng
Lifeng Gan
Fangtao Zhang
Biao Qian

Frontiers in Immunology

doi 10.3389/fimmu.2024.1486229

801 views

Original Research

Published on 31 Oct 2024

Comparison of the efficacy and safety of neoadjuvant PD-1 inhibitors plus chemotherapy vs targeted therapy plus chemotherapy in locally advanced hypopharyngeal squamous cell carcinoma

in Cancer Immunity and Immunotherapy

Wen Gao
Lifei Feng
Xinming Zhao
Zishi Huang
Duoxuan Chen
Gaofei Yin
Wei Guo
Qi Zhong
Xiaohong Chen
Jugao Fang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1466310

411 views

Case Report

Published on 31 Oct 2024

Case report: Partial regression of metastatic squamous cell carcinoma with altered azathioprine dosage after long-term use in renal transplant patient

in Cancer Immunity and Immunotherapy

Tegan Ormston
Jessica Da Gama Duarte
Luke T. Quigley
Louise Jackett
John Whitlam
Andreas Behren
David E. Gyorki

Frontiers in Immunology

doi 10.3389/fimmu.2024.1474663

535 views

Original Research

Published on 31 Oct 2024

E2F1-induced autocrine IL-6 inflammatory loop mediates cancer-immune crosstalk that predicts T cell phenotype switching and therapeutic responsiveness

in Cancer Immunity and Immunotherapy

Alf Spitschak
Prabir Dhar
Krishna P. Singh
Rosaely Casalegno Garduño
Shailendra K. Gupta
Julio Vera
Luca Musella
Nico Murr
Anja Stoll
Brigitte M. Pützer

Frontiers in Immunology

doi 10.3389/fimmu.2024.1470368

914 views

Original Research

Accepted on 30 Oct 2024

LRMAHpan: a novel tool for multi-allelic HLA presentation prediction using Resnet-based and LSTM-based neural networks

in Cancer Immunity and Immunotherapy

Xue Mi
Shaohao Li
Zheng Ye
Zhu Dai
Bo Ding
Bo Sun
Zhongdang Xiao
Shen Yang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1478201

Review

Accepted on 30 Oct 2024

Wound Healing: Insights into Autoimmunity, Ageing, and Cancer Ecosystems through Inflammation and IL-6 Modulation

in Cancer Immunity and Immunotherapy

Lukas Lacina
Michal Kolář
Lucie Pfeiferová
Peter Gal
Karel Smetana Jr.

Frontiers in Immunology

doi 10.3389/fimmu.2024.1403570

Original Research

Accepted on 30 Oct 2024

Heterogeneous Immune Landscapes and Macrophage Dynamics in Primary and Lung Metastatic Adenoid Cystic Carcinoma of the Head and Neck

in Cancer Immunity and Immunotherapy

Xuelian Wang
Tingyao Ma
Hongfei Liu
Shujing Zhang
Guoliang Yang
Yue Zhao
Lu Kong
Ran Gao
Xiaohong Chen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1483887

Original Research

Published on 30 Oct 2024

Integrated multi-level omics profiling of disulfidptosis identifis SPAG4 as an innovative immunotherapeutic target in glioblastoma

in Cancer Immunity and Immunotherapy

Shenbo Chen
Man Zeng
Taixue Chen
Hui Ding
JiaHan Lin
Fuyue Ye
Ran Wu
Liangwang Yang
Kun Yang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1462064

767 views

Review

Published on 30 Oct 2024

Oncolytic viruses: a potential breakthrough immunotherapy for multiple myeloma patients

in Cancer Immunity and Immunotherapy

Vincenzo Raimondi
Rosanna Vescovini
Mattia Dessena
Gaetano Donofrio
Paola Storti
Nicola Giuliani

Frontiers in Immunology

doi 10.3389/fimmu.2024.1483806

769 views

Original Research

Published on 30 Oct 2024

Comprehensive multi-omics analysis identifies chromatin regulator-related signatures and TFF1 as a therapeutic target in lung adenocarcinoma through a 429-combination machine learning approach

in Cancer Immunity and Immunotherapy

Jun Fan
BoGuang Chen
Hao Wu
Xiaoqing Liang
Wen Shen
Xiaye Miao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1481753

671 views

Review

Published on 30 Oct 2024

The role of cuproptosis in gastric cancer

in Cancer Immunity and Immunotherapy

Yixian Li
Wenhao Sun
Shaolin Yuan
Xinxin Liu
Ziqi Zhang
Renjun Gu
Pengfei Li
Xin Gu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1435651

702 views

Review

Published on 30 Oct 2024

LncRNAs in tumor metabolic reprogramming and tumor microenvironment remodeling

in Cancer Immunity and Immunotherapy

Jianhang Jiao
Yangzhi Zhao
Qimei Li
Shunzi Jin
Zhongshan Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1467151

417 views

Navigation group

Articles

Associations between tertiary lymphoid structure density and immune checkpoint inhibitor efficacy in solid tumors: systematic review and meta-analysis

Insights into the historical trajectory and research trends of immune checkpoint blockade in colorectal cancer: visualization and bibliometric analysis

Transcriptomics profiling of the non-small cell lung cancer microenvironment across disease stages reveals dual immune cell-type behaviors

Role and therapeutic potential of E3s in the tumor microenvironment of hepatocellular carcinoma

Critical role of non-coding RNA-mediated ferroptosis in urologic malignancies

Comparison of the efficacy and safety of neoadjuvant PD-1 inhibitors plus chemotherapy vs targeted therapy plus chemotherapy in locally advanced hypopharyngeal squamous cell carcinoma

Case report: Partial regression of metastatic squamous cell carcinoma with altered azathioprine dosage after long-term use in renal transplant patient

E2F1-induced autocrine IL-6 inflammatory loop mediates cancer-immune crosstalk that predicts T cell phenotype switching and therapeutic responsiveness

LRMAHpan: a novel tool for multi-allelic HLA presentation prediction using Resnet-based and LSTM-based neural networks

Wound Healing: Insights into Autoimmunity, Ageing, and Cancer Ecosystems through Inflammation and IL-6 Modulation

Heterogeneous Immune Landscapes and Macrophage Dynamics in Primary and Lung Metastatic Adenoid Cystic Carcinoma of the Head and Neck

Integrated multi-level omics profiling of disulfidptosis identifis SPAG4 as an innovative immunotherapeutic target in glioblastoma

Oncolytic viruses: a potential breakthrough immunotherapy for multiple myeloma patients

Comprehensive multi-omics analysis identifies chromatin regulator-related signatures and TFF1 as a therapeutic target in lung adenocarcinoma through a 429-combination machine learning approach

The role of cuproptosis in gastric cancer

LncRNAs in tumor metabolic reprogramming and tumor microenvironment remodeling